Month: April 2021

Context Therapeutics and Integral Molecular Enter Collaboration and License Deal for Novel Claudin 6 Antibodies for Gynecologic Cancer Therapeutic Program

Staff April 8, 2021

PHILADELPHIA, April 08, 2021 (GLOBE NEWSWIRE) -- Context Therapeutics, a clinical-stage women’s oncology company developing advanced small molecule and immunotherapy...

Luna Launches Innovative Capabilities for Orthopedic Groups to Standardize the Quality of Outpatient Physical Therapy

Staff April 8, 2021

Luna Protocols allows surgeons to ensure protocol compliance and clinical escalations for care offered on the platformROCKLIN, Calif., April 08,...

Avadel to Present New Data from its Pivotal REST-ON Phase 3 Study of FT218 at the American Academy of Neurology Annual Meeting 2021

Staff April 8, 2021

DUBLIN, Ireland, April 08, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an...

aTyr Pharma Announces Co-Founder of the Foundation for Sarcoidosis Research and Leading Sarcoidosis Advocate Andrea Wilson as Patient Advisor

Staff April 8, 2021

Ms. Wilson to advise company on patient strategies related to clinical program for ATYR1923 in pulmonary sarcoidosisSAN DIEGO, April 08,...

Former FDA Psychiatry Division Director Dr. Thomas Laughren Joins BetterLife as Regulatory Advisor

Staff April 8, 2021

VANCOUVER, British Columbia, April 08, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB :...

Spectral Medical’s Dialco Medical Announces 20 Year Exclusive License Agreement for DIMI Hemodialysis System in the United States and Canada

Staff April 8, 2021

TORONTO, April 08, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), today announced that its...

NeuBase Therapeutics to Host a Virtual R&D Day on June 8th to Provide Updates on the Drug Development Pipeline Targeting Genetic Diseases

Staff April 8, 2021

PITTSBURGH, April 08, 2021 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology company accelerating...

Aptose to Present at Canaccord Genuity 2021 Horizons in Oncology Virtual Conference

Staff April 8, 2021

SAN DIEGO and TORONTO, April 08, 2021 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company...

electroCore Announces Top Line Results from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients

Staff April 8, 2021

nVNS decreases certain biomarkers associated with the severity of COVID-19 through five days of treatmentROCKAWAY, NJ, April 08, 2021 (GLOBE...

Matinas BioPharma to Present at the Needham Healthcare Conference

Staff April 8, 2021

BEDMINSTER, N.J., April 08, 2021 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that Jerome D....

Generation Bio to Present at 20th Annual Needham Virtual Healthcare Conference

Staff April 8, 2021

CAMBRIDGE, Mass., April 08, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a...

Venus Concept to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021

Staff April 8, 2021

TORONTO, April 08, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical...

Plus Therapeutics to Announce First Quarter 2021 Financial Results and Host Conference Call on April 22, 2021

Staff April 8, 2021

AUSTIN, Texas, April 08, 2021 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing novel,...

Progenity to Present Key Prospective Verification Study Data for its Preeclampsia Rule-Out Test at 2021 American College of Obstetricians and Gynecologists Annual Meeting

Staff April 8, 2021

SAN DIEGO, April 08, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record...

Month: April 2021

Context Therapeutics and Integral Molecular Enter Collaboration and License Deal for Novel Claudin 6 Antibodies for Gynecologic Cancer Therapeutic Program

Luna Launches Innovative Capabilities for Orthopedic Groups to Standardize the Quality of Outpatient Physical Therapy

Avadel to Present New Data from its Pivotal REST-ON Phase 3 Study of FT218 at the American Academy of Neurology Annual Meeting 2021

aTyr Pharma Announces Co-Founder of the Foundation for Sarcoidosis Research and Leading Sarcoidosis Advocate Andrea Wilson as Patient Advisor

Former FDA Psychiatry Division Director Dr. Thomas Laughren Joins BetterLife as Regulatory Advisor

Spectral Medical’s Dialco Medical Announces 20 Year Exclusive License Agreement for DIMI Hemodialysis System in the United States and Canada

NeuBase Therapeutics to Host a Virtual R&D Day on June 8th to Provide Updates on the Drug Development Pipeline Targeting Genetic Diseases

Aptose to Present at Canaccord Genuity 2021 Horizons in Oncology Virtual Conference

electroCore Announces Top Line Results from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients

Matinas BioPharma to Present at the Needham Healthcare Conference

Generation Bio to Present at 20th Annual Needham Virtual Healthcare Conference

Venus Concept to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021

Plus Therapeutics to Announce First Quarter 2021 Financial Results and Host Conference Call on April 22, 2021

Progenity to Present Key Prospective Verification Study Data for its Preeclampsia Rule-Out Test at 2021 American College of Obstetricians and Gynecologists Annual Meeting

Inozyme Pharma to Present Burden of Illness Data at the 2021 ACMG Annual Clinical Genetics Meeting

MediPharm Labs Completes Its First High THC Cannabis Oil Export to Peru

THC Therapeutics Engage Milestone Management Services for Investor Relations

Athira Pharma to Host Educational Webinar on Targeting HGF/MET: A Naturally Occurring Neuronal Repair Pathway

Anavex Life Sciences to Present at the 20th Annual Needham Virtual Healthcare Conference

Bolt Biotherapeutics to Present at 20th Annual Needham Virtual Healthcare Conference

MENU – ORDER AI Announces Global Expansion with New Multilingual Capabilities, Supporting WHO Guidance on Dietary Needs for GLP-1 Users

AMEEREX Signs MOU to Acquire 45.6 million-Ounce Silver-Gold Project in Nevada, Expanding Its North American Precious-Metals Portfolio

Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting

Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition

Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company’s RXR agonist compound IRX4204 has synergistic efficacy against human multiple myeloma

You may have missed